Page last updated: 2024-08-22

magnesium sulfate and Cerebral Palsy

magnesium sulfate has been researched along with Cerebral Palsy in 178 studies

Research

Studies (178)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	17 (9.55)	18.2507
2000's	39 (21.91)	29.6817
2010's	99 (55.62)	24.3611
2020's	23 (12.92)	2.80

Authors

Authors	Studies
Callander, E; Cavallaro, A; Crowther, C; Groves, C; Keir, A; Mcintyre, S; Rumbold, A; Shepherd, E	1
Carlsson, Y; Hagberg, H; Jonsdotter, A; Rocha-Ferreira, E	1
André, C; Curioni, CC; da Silva, ACF; de Velasco, PC; Lamarca, F; Mocellin, MC; Ribas, SA; Tavares, MDS	1
Ayala, NK; Blackwell, SC; Caritis, SN; Costantine, MM; deRegnier, RO; Dizon, MLV; Rouse, DJ; Saad, AF; Thorp, JM; Varner, MW; Wapner, RJ; Weiner, SJ	1
Ashwood, P; Crowther, CA; Harding, JE; McPhee, A; Middleton, PF; Tran, T	1
Ådén, U; Ågren, J; Carlsson, Y; Domellöf, M; Hagberg, H; Hellström, S; Herbst, A; Jonsdotter, A; Jonsson, M; Pettersson, K; Saltvedt, S	1
Carrascosa García, P; Fernández Monteagudo, B; Sánchez Luna, M; Villar Castro, S; Zeballos Sarrato, S	1
Brok, J; Greisen, G; Hedegaard, M; Hegaard, HK; Henriksen, TB; Huusom, LD; Pinborg, A; Pryds, O; Salvig, JD; Weber, T; Wolf, HT	2
Brok, J; Hegaard, HK; Henriksen, TB; Huusom, LD; Pinborg, A; Wolf, HT	1
Alfirevic, Z; Gates, S	1
Grobman, WA	1
Ashwood, P; Crowther, CA; Doyle, LW; Makrides, M; Mcintyre, S; Middleton, P; Shepherd, E; Smithers-Sheedy, H; Sullivan, TR; Te Velde, A	1
Greisen, G; Hoei-Hansen, CE; Krebs, L; Larsen, ML; Rackauskaite, G	1
Adams-Chapman, I	1
Blanchard, CT; Harper, LM; Harris, SL; Robbins, LS; Sinkey, RG; Tita, AT	1
Brok, JS; Hegaard, HK; Henriksen, TB; Huusom, LD; Larsen, ML; Pinborg, A; Wolf, HT	1
Anderson, PJ; Boland, RA; Cheong, JLY; Doyle, LW; Kwong, A; Lee, KJ; Olsen, JE; Spittle, AJ	1
Bertrand, E; Chollat, C; Dabaj, I; de Vansay, C; Gillibert, A; Marret, S; Petit-Ledo, A; Voisin, C	1
Callander, EJ; Crowther, C; Groves, C; Keir, AK; McIntyre, S; Rumbold, A; Shepherd, E	1
Blanchard, C; Bushman, ET; Casey, B; Harper, LM; Harris, S; Ramani, M; Sinkey, RG; Tita, AT	1
Edwards, JM; Edwards, LE; Grotegut, CA; Swamy, GK	2
Brookfield, KF; Carvalho, B; Drover, DR; Elkomy, M; Su, F	1
Pang, J	1
Badawi, N; Crowther, CA; Makrides, M; McIntyre, S; Middleton, P; Salam, RA; Shepherd, E	1
Concheiro Guisán, A; Durán Fernández-Feijoo, C; Fernández Lorenzo, JR; García Alonso, L; González Colmenero, E; González Durán, L; Pumarada Prieto, M; Suárez Albo, M	1
Askie, L; Crowther, CA; Doyle, LW; Duley, L; Marret, S; Middleton, PF; Pryde, PG; Voysey, M	1
Dietz, RM; Paulsen, ME	2
Bone, JN; De Silva, DA; Lee, T; Magee, LA; Synnes, AR; von Dadelszen, P	1
Caritis, SN; Clark, EAS; Dudley, DJ; Hankins, GDV; Iams, JD; Malone, FD; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Reddy, UM; Rouse, DJ; Sorokin, Y; Wapner, RJ; Weiner, SJ	1
Ancel, PY; Benhammou, V; d'Ercole, C; Delorme, P; Foix-L'Hélias, L; Gire, C; Goffinet, F; Kayem, G; Lorthe, E; Marchand-Martin, L; Sentilhes, L; Subtil, D; Torchin, H; Winer, N	1
Huusom, LD; Wolf, HT	1
Haak, P; Korzeniewski, SJ; Lenski, M; Paneth, N; Slaughter, J	1
Cleren, C; Daher, I; Dourmap, N; Dupré, N; Gonzalez, BJ; Le Dieu-Lugon, B; Lecointre, M; Leroux, P; Leroux-Nicollet, I; Marret, S; Voisin, C	1
Barrett, JF; Kingdom, JC; McDonald, SD; Monterrosa, L; Shah, PS; Stockley, EL; Synnes, AR; Ting, JY	1
Buhimschi, CS; Buhimschi, IA; Hay, K; Kellert, BA; Maitre, NL; Stetson, BT	1
Buhimschi, C; Caritis, SN; Carpenter, M; Costantine, MM; Dudley, DJ; Jablonski, KA; Leveno, KJ; Malone, FD; Mercer, BM; O'sullivan, MJ; Peaceman, AM; Ramin, SM; Reddy, UM; Rouse, DJ; Sorokin, Y; Thorp, JM; Varner, MW; Wapner, RJ	1
Bénichou, J; Chollat, C; Houivet, E; Joly, A; Marret, S	1
Bernstein, HB; Jameson, RA	1
Crowther, C; Gatman, K; May, R	1
Bain, E; Crowther, CA; Nguyen, TM; Wilkinson, D	1
Ashwood, P; Crowther, CA; Haslam, R; Middleton, PF; Wilkinson, D	1
Ashwood, P; Bain, E; Bubner, T; Crowther, C; Goodchild, L; Lontis, R; McIntyre, S; Middleton, P	1
Basu, SK; Bhutada, A; Borja-Del-Rosario, P; Haberman, S; Rastogi, S	1
Andonotopo, W; Bachnas, MA; Effendi, JS; Mose, JC	1
Gibbins, KJ; Rouse, DJ	1
Basso, M; Bickford, CD; Kruse, M; Magee, LA; Mitton, C; Sawchuck, D; Senikas, VM; Synnes, AR; von Dadelszen, P	1
Ashwood, P; Bain, E; Bubner, T; Crowther, CA; Flenady, V; McIntyre, S; Middleton, PF; Morris, J	1
Ashwood, PJ; Bain, ES; Crowther, CA; Middleton, PF; Yelland, LN	1
Koren, G; Namouz-Haddad, S	1
Berggren, EK; Leung, EY	1
Manuck, TA; Sheng, X; Varner, MW; Yoder, BA	1
Bénichou, J; Chollat, C; Enser, M; Houivet, E; Marpeau, L; Marret, S; Provost, D	1
Caritis, SN; Carpenter, M; Dudley, DJ; Hankins, GD; Iams, JD; Jablonski, KA; Leveno, KJ; Malone, FD; Marshall, NE; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Reddy, UM; Rouse, DJ; Sorokin, Y; Thorp, JM; Varner, MW; Wapner, RJ	1
Arora, KS; Miller, ES	1
Grobman, WA; McPherson, JA; Palatnik, A; Rouse, DJ; Stamilio, DM	2
Haas, J; Kalter, A; Marom-Haham, L; Mazaki-Tovi, S; Schiff, E; Sivan, E; Yinon, Y; Zilberman, I	1
Anderson, PJ; Crowther, C; Doyle, LW; Haslam, R; Lee, KJ	1
Caritis, SN; Hankins, GD; Horton, AL; Iams, JD; Lai, Y; Leveno, KJ; Malone, FD; Mercer, BM; O'Sullivan, MJ; Ramin, SM; Rouse, DJ; Sorokin, Y; Spong, CY; Thorp, JM; Varner, MW; Wapner, RJ	1
Groom, KM; Tan, YH	1
Jacquemyn, Y; Roelens, K; Van Laere, D; Zecic, A	1
Cho, GJ; Hong, HR; Hong, SC; Kim, HJ; Oh, MJ	1
Bénichou, J; Marret, S	1
Anderson, PJ; Doyle, LW; Lee, KJ	1
McGuire, W; Oddie, S; Tuffnell, DJ	1
Consonni, S; Ghidini, A; Locatelli, A	1
Chauhan, SP; Hammad, IA; Marrs, CC; Mendez-Figueroa, H	1
Drassinower, D; Friedman, AM; Gyamfi-Bannerman, C; Levin, H; Običan, SG	2
Clark, E; Kamyar, M; Manuck, TA; Stoddard, GJ; Varner, MW	1
Ashwood, P; Bain, E; Bubner, T; Crowther, CA; Middleton, P; Siwicki, K	1
Drassinower, D; Gyamfi-Bannerman, C; Levin, H; Običan, SG; Small, A; Smith, D	1
McPherson, J; Smiley, S; Stamilio, D	1
Bulas, D; Caritis, SN; Carpenter, MW; DiPietro, M; Dudley, D; Hankins, GD; Hirtz, DG; Iams, JD; Malone, FD; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Reddy, UM; Rouse, DJ; Seibert, J; Sorokin, Y; Thorp, JM; Varner, MW; Wapner, RJ; Weiner, SJ	1
Ashwood, P; Bain, E; Bubner, T; Crowther, CA; Middleton, P; Reid, S; Simmonds, L; Van Ryswyk, E	1
Baisson, AL; Bouet, PE; Brun, S; Courtay, V; Gascoin-Lachambre, G; Lasocki, S; Madar, H; Sentilhes, L	1
Basso, M; Chapman, K; De Silva, DA; Liston, RM; Magee, LA; Sawchuck, D; Synnes, AR; Teela, KC; von Dadelszen, P	1
An, R; Sun, R; Tian, Q; Xue, Y; Zeng, X	1
Hirtz, D; Rouse, DJ	1
Ikenoue, T; Kawagoe, Y; Ohhashi, M; Sameshima, H; Satoh, S; Sumiyoshi, K; Yoshitomi, T	1
Gyamfi-Bannerman, C; Too, GT; Turitz, AL	1
Escalona-Vargas, DI; Eswaran, H; Lowery, CL; Magann, EF; McGrail, K; Napolitano, PG; Thagard, AS	1
McPherson, JA; Smid, MC; Smiley, S; Stamilio, DM	1
Dotters-Katz, SK; Manuck, TA; Metz, TD; Smid, MC	1
Ancel, PY; Marret, S	1
Gianopoulos, JG; Mittendorf, R; Pryde, PG; Roizen, N; Won, SY	1
Alexander, JM; Caritis, SN; Carpenter, M; Hankins, GD; Harper, M; Hirtz, DG; Iams, JD; Langer, O; Malone, FD; Mercer, BM; Miodovnik, M; Moawad, A; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Roberts, JM; Rouse, DJ; Sorokin, Y; Spong, CY; Thom, E; Thorp, JM; Varner, MW; Wapner, RJ	1
Crowther, C; Stanley, FJ	1
Babina, LM; Gurova, NY	1
Mittendorf, R; Pryde, PG	4
Crowther, CA; Doyle, LW; Marret, S; Middleton, P; Rouse, D	1
Elliott, JP; Garite, TJ; Lewis, DF; Morrison, JC	1
Crowther, CA; Doyle, LW; Marret, S; Middleton, P	3
Macones, GA	1
Cahill, AG; Caughey, AB	1
Rouse, DJ	2
Conde-Agudelo, A; Romero, R	1
Costantine, MM; Weiner, SJ	1
Scott, JR	1
Andrews, J	1
Gardener, GJ; Knight, DB	1
Gonen, R	1
Do, SH; Han, SH; Hwang, JY; Jeon, YT; Lee, JH; Na, HS; Ryu, JH	1
Cahill, AG; Caughey, AB; Stout, MJ	1
Brocklehurst, P; Marlow, N; Peebles, DM	1
Brok, J; Gluud, C; Huusom, LD; Pryds, O; Secher, NJ; Whitfield, K	1
Chollat, C; Levèque, C; Marpeau, L; Marret, S	1
Dubuisson, JB; Irion, O; Julen, O; Lourenço, AG; Yaron, M	1
Greisen, G; Hedegaard, M; Hegaard, HK; Huusom, L; Wolf, HT	2
Imberger, G; Wetterslev, J	1
Crowther, C; Doyle, L; Marret, S; Middleton, P; Rouse, D; Voysey, M	1
Costantine, MM; Drever, N	1
Matsuda, Y; Mitani, M; Shimada, E	1
Basu, SK; Bhutada, A; Chickajajur, V; Lopez, V; Pagala, M; Rastogi, S	1
Brennecke, S; Costa, Fda S; Lopes, L	1
Cahill, AG; Caughey, AB; Grobman, WA; Macones, GA; Odibo, AO; Stout, MJ	1
Sibai, BM	1
Evans, N; Kluckow, M; Osborn, DA; Paradisis, M	1
Doyle, LW	1
Combs, CA; Garite, TJ	1
Kennedy, A; McCarthy, EA; Ow, LL; Walker, SP	1
Haddad, B; Kayem, G; Mandelbrot, L	1
Brok, J; Hegaard, HK; Huusom, LD; Pryds, O; Secher, NJ	1
Brok, J; Huusom, LD; Thorlund, K	1
Ashwood, P; Bain, E; Bubner, T; Crowther, CA; Middleton, P	1
Dean, C; Douglas, J	1
Repke, JT	1
Anderson, BL; Browning, KR; Gibbins, KJ; Lopes, VV; Rouse, DJ	1
Lee, KS; Mittendorf, R; Pryde, PG	1
Crowther, CA; Doyle, LW; Haslam, RR; Hiller, JE	1
Gilstrap, LC; Tyson, JE	1
Lee, KS; Mittendorf, R; Pryde, PG; Roizen, NJ	1
Ananth, CV; Vintzileos, AM	1
Mittendorf, R; Pryde, PG; Roizen, N	1
Mittendorf, R; Pryde, PG; Roizen, NJ	1
Janeczek, S; Mittendorf, R; Pryde, PG	1
Itakura, A; Matsuzawa, K; Mizutani, S; Murata, Y; Okumura, A; Wakai, K	1
Dammann, O; Lee, KS; Mittendorf, R	1
Blair, E; Watson, L	1
Bénichou, J; Eurin, D; Hellot, MF; Lévêque, C; Marpeau, L; Marret, S; Zupan-Simunek, V	1
Astruc, D; Bénichou, J; Bruel, H; Cambonie, G; Delaporte, B; Follet-Bouhamed, C; Guillois, B; Marpeau, L; Marret, S; Pinquier, D; Zupan-Simunek, V	1
Babina, LM; Gurova, NIu	1
Grether, JK; Nelson, KB	2
Blair, E; Palmer, L; Stanley, F	1
Cummins, SK; Emery, ES; Grether, JK; Nelson, KB	1
Goldenberg, RL; Hauth, JC; Nelson, KG; Rouse, DJ	1
Berg, CJ; Boyle, CA; Decoufle, P; Schendel, DE; Yeargin-Allsopp, M	1
Nelson, KB	1
Allred, EN; Dammann, O; Kuban, KK; Leviton, A; Pagano, M; Stewart, JE; VanMarter, LJ	1
Allred, EN; Hegyi, T; Hiatt, M; Kuban, K; Leviton, A; Paneth, N; Reuss, ML; Sanocka, U; Shahrivar, F; Susser, M; Van Marter, LJ	1
Jetton, J; Paneth, N; Pinto-Martin, J; Susser, M	1
Grether, JK; Hoogstrate, J; Nelson, KB; Selvin, S	1
Capuzzo, E; Cavallini, A; De Santolo, A; Fazzi, E; Spinillo, A; Stronati, M	1
Hirtz, DG; Nelson, K	1
Aird, I; Luckas, M	1
Galvin, KA; Oorschot, DE	1
Bac, P; Bara, M; Durlach, J; Guiet-Bara, A	1
Hatae, M; Hiroyama, Y; Ibara, S; Kamitomo, M; Kouno, S; Kuraya, K; Matsuda, Y	1
Boyle, CA; Holmgreen, P; Oakley, GP; Schendel, DE; Yeargin-Allsopp, M	1
Grether, JK; Hoogstrate, J; Nelson, KB; Walsh-Greene, E	1
Oorschot, DE	1
Bentz, L; Hinson, R; Ismail, M; Mittendorf, R; Montag, A; Naccasha, N	1
Palmer, FB; Petersen, MC	1
Besinger, RE; Dambrosia, J; Gianopoulos, JG; Lee, KS; Mittendorf, R; Pryde, PG; Tomich, PG	1
Fenton, T; Kuban, KC; Leviton, A; Pagano, M; Strassfeld, R; Wolff, M	1

Reviews

42 review(s) available for magnesium sulfate and Cerebral Palsy

Article	Year
Effectiveness of nutritional interventions to prevent nonprogressive congenital and perinatal brain injuries: a systematic review and meta-analysis of randomized trials. Nutrition reviews, 2022, 10-10, Volume: 80, Issue:11 Topics: Acetylcysteine; Brain Injuries; Cerebral Palsy; Child; Choline; Docosahexaenoic Acids; Female; Fetal Alcohol Spectrum Disorders; Humans; Infant; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Randomized Controlled Trials as Topic; Uridine Monophosphate; Vitamin A; Vitamin D	2022
Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis. BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:10 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Risk Assessment	2020
[Magnesium sulphate treatment decreases the risk of cerebral palsy after preterm birth]. Ugeskrift for laeger, 2020, 11-16, Volume: 182, Issue:47 Topics: Cerebral Palsy; Child; Female; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotection; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic	2020
Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews. The Cochrane database of systematic reviews, 2017, 08-08, Volume: 8 Topics: Antibiotic Prophylaxis; Cerebral Palsy; Female; Fetal Distress; Humans; Hypertension; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Parturition; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Review Literature as Topic	2017
Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis. PLoS medicine, 2017, Volume: 14, Issue:10 Topics: Cerebral Palsy; Dose-Response Relationship, Drug; Female; Fetal Blood; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Outcome and Process Assessment, Health Care; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Time-to-Treatment	2017
Antenatal magnesium sulfate treatment for women at risk of preterm birth is safe and might decrease the risk of cerebral palsy. BMJ evidence-based medicine, 2018, Volume: 23, Issue:5 Topics: Cerebral Palsy; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Premature Birth; Prenatal Care	2018
The complex aetiology of cerebral palsy. Nature reviews. Neurology, 2018, Volume: 14, Issue:9 Topics: Anticonvulsants; Cerebral Palsy; Child; Congenital Abnormalities; Female; Genetic Predisposition to Disease; Humans; Hypothermia, Induced; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Pregnancy Complications	2018
Magnesium Sulfate and Novel Therapies to Promote Neuroprotection. Clinics in perinatology, 2019, Volume: 46, Issue:2 Topics: Cerebral Palsy; Darbepoetin alfa; Erythropoietin; Female; Hematinics; Humans; Hypothermia, Induced; Infant, Newborn; Infant, Premature; Ischemic Preconditioning; Magnesium Sulfate; Maternal-Fetal Exchange; Mesenchymal Stem Cell Transplantation; Neuroprotection; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Premature Birth	2019
Magnesium sulphate for women at term for neuroprotection of the fetus. The Cochrane database of systematic reviews, 2013, Feb-28, Issue:2 Topics: Brain Injuries; Cerebral Palsy; Female; Fetus; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic	2013
A moving line in the sand: a review of obstetric management surrounding periviability. Obstetrical & gynecological survey, 2014, Volume: 69, Issue:6 Topics: Adrenal Cortex Hormones; Cerebral Palsy; Cesarean Section; Directive Counseling; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Extremely Premature; Magnesium Sulfate; Patient Education as Topic; Patient Participation; Pregnancy; Premature Birth	2014
The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection. Archives of gynecology and obstetrics, 2015, Volume: 291, Issue:5 Topics: Administration, Intravenous; Australia; Canada; Cerebral Palsy; Female; Fetus; Humans; Infant, Newborn; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Premature Birth; Risk Assessment	2015
Antenatal magnesium sulfate: Neuro-protection for preterm infants. Archives of disease in childhood. Fetal and neonatal edition, 2015, Volume: 100, Issue:6 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Pregnancy	2015
Preterm labor: approach to decreasing complications of prematurity. Obstetrics and gynecology clinics of North America, 2015, Volume: 42, Issue:2 Topics: Adrenal Cortex Hormones; Adult; Cerebral Palsy; Cesarean Section; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Prognosis; Tocolytic Agents	2015
Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines. Medicine, 2016, Volume: 95, Issue:1 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Mothers; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy	2016
What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy. Seminars in perinatology, 2016, Volume: 40, Issue:5 Topics: Adult; Case-Control Studies; Cerebral Palsy; Double-Blind Method; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pilot Projects; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Treatment Outcome	2016
[Neuroprotection for preterm infants with antenatal magnesium sulphate]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2016, Volume: 45, Issue:10 Topics: Adult; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth	2016
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1 Topics: Central Nervous System Diseases; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic	2009
In defense of magnesium sulfate. Obstetrics and gynecology, 2009, Volume: 113, Issue:6 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents	2009
Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstetrics and gynecology, 2009, Volume: 113, Issue:6 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy	2009
Magnesium for neuroprophylaxis: fact or fiction? American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:6 Topics: Cerebral Palsy; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Prospective Studies; Randomized Controlled Trials as Topic	2009
Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:6 Topics: Cerebral Palsy; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Randomized Controlled Trials as Topic	2009
Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstetrics and gynecology, 2009, Volume: 114, Issue:2 Pt 1 Topics: Cerebral Palsy; Female; Fetus; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Mortality; Pregnancy; Randomized Controlled Trials as Topic; Tocolytic Agents	2009
Intrapartum magnesium for prevention of cerebral palsy: continuing controversy? Current opinion in obstetrics & gynecology, 2010, Volume: 22, Issue:2 Topics: Cerebral Palsy; Female; Gestational Age; Humans; Magnesium Sulfate; Pregnancy; Pregnancy, High-Risk; Prenatal Care; Tocolytic Agents	2010
[Prevention of cerebral palsy using magnesium sulfate in pre-term newborns]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2011, Volume: 18, Issue:3 Topics: Animals; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Meta-Analysis as Topic; Models, Animal; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic	2011
Using prophylactic, but not tocolytic, magnesium sulfate to reduce cerebral palsy related to prematurity: what dose, and what about infant mortality? Journal of perinatal medicine, 2011, Volume: 39, Issue:4 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Meta-Analysis as Topic; Models, Biological; Pregnancy; Randomized Controlled Trials as Topic; Tocolysis; Tocolytic Agents	2011
Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants. Obstetrics and gynecology clinics of North America, 2011, Volume: 38, Issue:2 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Prenatal Care; Tocolytic Agents	2011
Antenatal magnesium sulfate and neuroprotection. Current opinion in pediatrics, 2012, Volume: 24, Issue:2 Topics: Cerebral Palsy; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Meta-Analysis as Topic; Neuroprotective Agents; Pregnancy; Prenatal Care; Randomized Controlled Trials as Topic	2012
Treatment with magnesium sulphate in pre-term birth: a systematic review and meta-analysis of observational studies. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2012, Volume: 32, Issue:2 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy	2012
Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE). Systematic reviews, 2012, Mar-21, Volume: 1 Topics: Cerebral Palsy; Evidence-Based Medicine; Female; Fetal Death; Humans; Infant Mortality; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Risk Factors	2012
[Use of magnesium sulfate in obstetrics]. Gynecologie, obstetrique & fertilite, 2012, Volume: 40, Issue:10 Topics: Cerebral Palsy; Eclampsia; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic	2012
Magnesium and the obstetric anaesthetist. International journal of obstetric anesthesia, 2013, Volume: 22, Issue:1 Topics: Adjuvants, Anesthesia; Analgesics; Anesthesia, Obstetrical; Anesthesiology; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Premature Birth	2013
Second overview of relationships between antenatal pharmacologic magnesium sulfate and neurologic outcomes in children. Journal of perinatal medicine, 2004, Volume: 32, Issue:3 Topics: Cerebral Palsy; Female; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic; Tocolytic Agents	2004
Risk-benefit effects of tocolytic therapy. Expert opinion on drug safety, 2004, Volume: 3, Issue:6 Topics: Adrenergic beta-Agonists; Adult; Calcium Channel Blockers; Cerebral Hemorrhage; Cerebral Palsy; Cyclooxygenase Inhibitors; Female; Fetal Diseases; Hormone Antagonists; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Oxytocin; Pre-Eclampsia; Pregnancy; Risk Assessment; Tocolysis; Tocolytic Agents	2004
A review of the role for magnesium sulphate in preterm labour. BJOG : an international journal of obstetrics and gynaecology, 2005, Volume: 112 Suppl 1 Topics: Cerebral Palsy; Eclampsia; Female; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic; Tocolytic Agents	2005
Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor. Journal of perinatology : official journal of the California Perinatal Association, 2006, Jan-01, Volume: 26, Issue:1 Topics: Basal Ganglia Cerebrovascular Disease; Cerebral Hemorrhage; Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prenatal Exposure Delayed Effects; Randomized Controlled Trials as Topic; Tocolytic Agents	2006
Epidemiology of cerebral palsy. Seminars in fetal & neonatal medicine, 2006, Volume: 11, Issue:2 Topics: Adrenal Cortex Hormones; Cerebral Palsy; Female; Gestational Age; Humans; Hypocapnia; Hypothermia, Induced; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Inflammation; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Pregnancy, Multiple; Severity of Illness Index; Tocolytic Agents	2006
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. The Cochrane database of systematic reviews, 2007, Jul-18, Issue:3 Topics: Central Nervous System Diseases; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Infant, Newborn, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic	2007
Magnesium sulfate and cerebral palsy in premature infants. Current opinion in pediatrics, 1998, Volume: 10, Issue:2 Topics: Animals; Cerebral Palsy; Cerebrovascular Circulation; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Tocolytic Agents	1998
Is the pharmacological use of intravenous magnesium before preterm cerebroprotective or deleterious for premature infants? Possible importance of the use of magnesium sulphate. Magnesium research, 1998, Volume: 11, Issue:4 Topics: Animals; Cerebral Palsy; Clinical Trials as Topic; Female; Fetus; Humans; Infant, Newborn; Infant, Premature; Injections, Intravenous; Magnesium; Magnesium Compounds; Magnesium Sulfate; Pregnancy; Tocolytic Agents	1998
An overview of the possible relationship between antenatal pharmacologic magnesium and cerebral palsy. Journal of perinatal medicine, 2000, Volume: 28, Issue:4 Topics: Cerebral Palsy; Female; Humans; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate; Tocolysis	2000
Cerebral palsy and experimental hypoxia-induced perinatal brain injury: is magnesium protective? Magnesium research, 2000, Volume: 13, Issue:4 Topics: Animals; Brain Injuries; Cerebral Palsy; Female; Humans; Hypoxia; Hypoxia-Ischemia, Brain; Magnesium; Magnesium Chloride; Magnesium Sulfate; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Rats; Sheep	2000
Advances in prevention and treatment of cerebral palsy. Mental retardation and developmental disabilities research reviews, 2001, Volume: 7, Issue:1 Topics: Botulinum Toxins, Type A; Cerebral Palsy; Clinical Trials as Topic; Female; Humans; Infant, Newborn; Magnesium Sulfate; Male; Muscle Spasticity; Pregnancy; Pregnancy, Multiple; Rhizotomy; Risk Factors; Treatment Outcome	2001

Trials

36 trial(s) available for magnesium sulfate and Cerebral Palsy

Article	Year
Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring: The MAGENTA Randomized Clinical Trial. JAMA, 2023, 08-15, Volume: 330, Issue:7 Topics: Administration, Intravenous; Adult; Asian; Australia; Australian Aboriginal and Torres Strait Islander Peoples; Cerebral Palsy; Child, Preschool; Female; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Maori People; New Zealand; Pacific Island People; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; White; Young Adult	2023
Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial. BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:10 Topics: Adult; Cerebral Palsy; Denmark; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Severity of Illness Index	2020
Prenatal Tobacco Exposure and Childhood Neurodevelopment among Infants Born Prematurely. American journal of perinatology, 2021, Volume: 38, Issue:3 Topics: Cerebral Palsy; Child, Preschool; Female; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Logistic Models; Magnesium Sulfate; Male; Multivariate Analysis; Pregnancy; Premature Birth; Risk Factors; Stillbirth; Tobacco Use; Vision Disorders	2021
Magnesium sulfate for neuroprotection in the setting of chorioamnionitis. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2018, Volume: 31, Issue:9 Topics: Adult; Cerebral Palsy; Chorioamnionitis; Female; Humans; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care	2018
Effect of Cord Blood Magnesium Level at Birth on Non-neurologic Neonatal Outcomes. American journal of perinatology, 2019, Volume: 36, Issue:1 Topics: Adult; Anticonvulsants; Bronchopulmonary Dysplasia; Cerebral Palsy; Enterocolitis, Necrotizing; Female; Fetal Blood; Humans; Infant, Newborn; Intellectual Disability; Magnesium; Magnesium Sulfate; Male; Outcome Assessment, Health Care; Pregnancy; Premature Birth; Retinopathy of Prematurity	2019
Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth. American journal of perinatology, 2018, Volume: 35, Issue:10 Topics: Case-Control Studies; Cerebral Palsy; Child, Preschool; Female; Genetic Variation; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature, Diseases; Logistic Models; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Neuroprotective Agents; Polymorphism, Single Nucleotide; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Receptors, Interleukin-6; Stillbirth	2018
Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol. BMC pregnancy and childbirth, 2013, Apr-09, Volume: 13 Topics: Blindness; Calcium Channel Blockers; Cerebral Palsy; Child Behavior; Child, Preschool; Deafness; Developmental Disabilities; Female; Gestational Age; Health Status; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Perinatal Mortality; Pregnancy; Premature Birth; Psychological Tests; Research Design; Stillbirth	2013
Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants. Journal of perinatal medicine, 2014, Volume: 42, Issue:1 Topics: Administration, Intravenous; Adult; Biomarkers; Brain-Derived Neurotrophic Factor; Cerebral Palsy; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Fetal Blood; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Care	2014
Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial. BJOG : an international journal of obstetrics and gynaecology, 2014, Volume: 121, Issue:5 Topics: Blood Pressure; Brain Injuries; Cerebral Hemorrhage; Cerebral Palsy; Cesarean Section; Diastole; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Respiratory Rate	2014
Correlation between initial neonatal and early childhood outcomes following preterm birth. American journal of obstetrics and gynecology, 2014, Volume: 210, Issue:5 Topics: Adult; Cerebral Palsy; Developmental Disabilities; Female; Health Status Indicators; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Premature Birth; Risk Factors; ROC Curve; Twins; Young Adult	2014
School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants. The Journal of pediatrics, 2014, Volume: 165, Issue:2 Topics: Adolescent; Cerebral Palsy; Child; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Male; Neuroprotective Agents; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Surveys and Questionnaires; Treatment Outcome	2014
The association of cord serum cytokines with neurodevelopmental outcomes. American journal of perinatology, 2015, Volume: 30, Issue:2 Topics: Adult; Case-Control Studies; Cerebral Palsy; Child Development; Child, Preschool; Cytokines; Developmental Disabilities; Female; Fetal Blood; Humans; Infant; Infant, Newborn; Infant, Premature; Interleukin-1beta; Interleukin-8; Logistic Models; Magnesium Sulfate; Pregnancy; Premature Birth; Prognosis; Tocolytic Agents; Tumor Necrosis Factor-alpha; Young Adult	2015
Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes. Obstetrics and gynecology, 2014, Volume: 124, Issue:4 Topics: Adult; Apgar Score; Birth Weight; Cerebral Palsy; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infusions, Intravenous; Logistic Models; Magnesium Sulfate; Male; Maternal Welfare; Neuroprotective Agents; Odds Ratio; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; Prospective Studies; Risk Assessment; Treatment Outcome	2014
School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo. JAMA, 2014, Sep-17, Volume: 312, Issue:11 Topics: Cerebral Palsy; Child Development; Cognition Disorders; Female; Follow-Up Studies; Humans; Infant Mortality; Infant, Extremely Premature; Infant, Newborn; Magnesium Sulfate; Male; Motor Skills Disorders; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Treatment Outcome	2014
Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes. American journal of perinatology, 2015, Volume: 32, Issue:4 Topics: Adult; Cerebral Palsy; Delivery, Obstetric; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents; Treatment Outcome; Young Adult	2015
Differential Morbidity in Preterm Small versus Appropriate for Gestational Age: Perhaps Unverifiable. American journal of perinatology, 2015, Volume: 32, Issue:13 Topics: Calcium Channel Blockers; Case-Control Studies; Cerebral Palsy; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Magnesium Sulfate; Multivariate Analysis; Perinatal Care; Pregnancy; Regression Analysis; Treatment Outcome	2015
Does magnesium exposure affect neonatal resuscitation? American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:3 Topics: Apgar Score; Cerebral Palsy; Female; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Linear Models; Magnesium Sulfate; Muscle Hypotonia; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Exposure Delayed Effects; Resuscitation	2015
Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth. BJOG : an international journal of obstetrics and gynaecology, 2016, Volume: 123, Issue:7 Topics: Adult; Cerebral Palsy; Chorioamnionitis; Female; Humans; Infant; Infant Mortality; Infant, Premature, Diseases; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Stillbirth	2016
Antenatal Magnesium and Cerebral Palsy in Preterm Infants. The Journal of pediatrics, 2015, Volume: 167, Issue:4 Topics: Cerebral Hemorrhage; Cerebral Palsy; Cerebral Ventricles; Child, Preschool; Cohort Studies; Electroencephalography; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Leukomalacia, Periventricular; Magnesium Sulfate; Male; Maternal Exposure; Neuroprotective Agents; Pregnancy; Ultrasonography	2015
Proximity of magnesium exposure to delivery and neonatal outcomes. American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:4 Topics: Adult; Cerebral Palsy; Delivery, Obstetric; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Odds Ratio; Placebos; Pregnancy; Premature Birth; Risk Factors; Time Factors	2016
Prolonged latency of preterm prelabour rupture of membranes and neurodevelopmental outcomes: a secondary analysis. BJOG : an international journal of obstetrics and gynaecology, 2016, Volume: 123, Issue:10 Topics: Adult; Body Mass Index; Cerebral Palsy; Delivery, Obstetric; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Magnesium Sulfate; Parturition; Pregnancy; Premature Birth; Risk Factors; Tocolytic Agents; United States	2016
Association of Maternal Obesity with Child Cerebral Palsy or Death. American journal of perinatology, 2017, Volume: 34, Issue:6 Topics: Adult; Cerebral Palsy; Cesarean Section; Female; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Logistic Models; Magnesium Sulfate; Male; Neuroprotective Agents; Obesity; Perinatal Death; Pregnancy; Pregnancy Complications; Premature Birth; Retrospective Studies; Severity of Illness Index; United States; Young Adult	2017
Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2017, Volume: 30, Issue:24 Topics: Cannabis; Cerebral Palsy; Child Development; Child, Preschool; Developmental Disabilities; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Male; Marijuana Abuse; Morbidity; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk Factors	2017
Relationships between umbilical cord arterial blood pH levels at delivery and Bayley Psychomotor Development Index scores in early childhood. Journal of perinatal medicine, 2008, Volume: 36, Issue:4 Topics: Adult; Apgar Score; Cerebral Palsy; Child Development; Cohort Studies; Double-Blind Method; Female; Fetal Blood; Humans; Hydrogen-Ion Concentration; Infant; Infant, Newborn; Magnesium Sulfate; Pregnancy; Prospective Studies; Psychomotor Performance; Random Allocation; Tocolytic Agents; Umbilical Cord	2008
A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. The New England journal of medicine, 2008, Aug-28, Volume: 359, Issue:9 Topics: Adult; Cerebral Palsy; Double-Blind Method; Female; Follow-Up Studies; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents	2008
Use of magnetophoresis of glutamic acid and magnesium sulfate in the rehabilitation of children with cerebral palsy. Neuroscience and behavioral physiology, 2008, Volume: 38, Issue:9 Topics: Administration, Cutaneous; Cerebral Palsy; Child; Child, Preschool; Combined Modality Therapy; Drug Combinations; Glutamic Acid; Humans; Infant; Magnesium Sulfate; Magnetic Field Therapy	2008
Effects of magnesium sulphate on intraoperative neuromuscular blocking agent requirements and postoperative analgesia in children with cerebral palsy. British journal of anaesthesia, 2010, Volume: 104, Issue:3 Topics: Adolescent; Analgesics; Analgesics, Opioid; Androstanols; Cerebral Palsy; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Female; Humans; Intraoperative Care; Magnesium Sulfate; Male; Neuromuscular Nondepolarizing Agents; Osteotomy; Pain Measurement; Pain, Postoperative; Rocuronium	2010
Randomized controlled trial of magnesium sulfate in women at risk of preterm delivery-neonatal cardiovascular effects. Journal of perinatology : official journal of the California Perinatal Association, 2012, Volume: 32, Issue:9 Topics: Cerebral Palsy; Echocardiography; Female; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Regional Blood Flow; Tocolytic Agents; Vena Cava, Superior; Ventricular Function, Right	2012
Does antenatal magnesium sulfate prevent cerebral palsy in preterm infants? The final trial? Acta obstetricia et gynecologica Scandinavica, 2012, Volume: 91, Issue:11 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Magnesium Sulfate; Pregnancy; Prenatal Care; Tocolytic Agents	2012
Evaluation of the clinical use of magnesium sulfate for cerebral palsy prevention. Obstetrics and gynecology, 2013, Volume: 121, Issue:2 Pt 1 Topics: Adult; Cerebral Palsy; Clinical Protocols; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care	2013
Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA, 2003, Nov-26, Volume: 290, Issue:20 Topics: Cerebral Palsy; Developmental Disabilities; Female; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk	2003
Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial. BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:3* Topics: Adult; Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Leukomalacia, Periventricular; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Tocolytic Agents	2007
[Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial]. Gynecologie, obstetrique & fertilite, 2008, Volume: 36, Issue:3 Topics: Adult; Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukomalacia, Periventricular; Longitudinal Studies; Magnesium Sulfate; Male; Morbidity; Nervous System Diseases; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Prospective Studies; Tocolytic Agents; Treatment Outcome	2008
Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. The Neonatal Brain Hemorrhage Study Analysis Group. Pediatrics, 1997, Volume: 99, Issue:5 Topics: Adult; Brain Diseases; Cerebral Hemorrhage; Cerebral Palsy; Cohort Studies; Confidence Intervals; Confounding Factors, Epidemiologic; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Labor, Obstetric; Logistic Models; Magnesium Sulfate; Odds Ratio; Pregnancy; Pregnancy Complications; Prospective Studies; Proteinuria; Risk Assessment; Survival Rate; Ultrasonography	1997
Association between funisitis and elevated interleukin-6 in cord blood. Obstetrics and gynecology, 2001, Volume: 97, Issue:2 Topics: Adult; Cerebral Hemorrhage; Cerebral Palsy; Chorioamnionitis; Female; Fetal Blood; Humans; Infant, Newborn; Interleukin-6; Magnesium Sulfate; Obstetric Labor, Premature; Placenta Diseases; Predictive Value of Tests; Pregnancy; Pregnancy, Multiple	2001
Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. American journal of obstetrics and gynecology, 2002, Volume: 186, Issue:6 Topics: Adult; Cerebral Hemorrhage; Cerebral Palsy; Female; Fetal Blood; Humans; Infant Mortality; Infant, Newborn; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prenatal Care; Risk Factors; Tocolytic Agents	2002

Other Studies

100 other study(ies) available for magnesium sulfate and Cerebral Palsy

Article	Year
Antenatal magnesium sulphate for preventing cerebral palsy: An economic evaluation of the impact of a quality improvement program. The Australian & New Zealand journal of obstetrics & gynaecology, 2022, Volume: 62, Issue:1 Topics: Cerebral Palsy; Child; Cost-Benefit Analysis; Female; Humans; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Quality Improvement	2022
Maternal and fetal serum concentrations of magnesium after administration of a 6-g bolus dose of magnesium sulfate (MgSO Acta obstetricia et gynecologica Scandinavica, 2022, Volume: 101, Issue:8 Topics: Cerebral Palsy; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care	2022
Differential Gene Expression in Cord Blood of Infants Diagnosed with Cerebral Palsy: A Pilot Analysis of the Beneficial Effects of Antenatal Magnesium Cohort. Developmental neuroscience, 2022, Volume: 44, Issue:4-5 Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biomarkers; Cerebral Palsy; Female; Fetal Blood; Gene Expression; Humans; Infant, Newborn; Infant, Premature; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Pregnancy	2022
A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth. Acta obstetricia et gynecologica Scandinavica, 2023, Volume: 102, Issue:12 Topics: Adult; Cerebral Palsy; Child; Feasibility Studies; Female; Follow-Up Studies; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotection; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Young Adult	2023
Neuroprotective effect of magnesium sulfate in premature infants. Analysis after establishing an antenatal administration protocol in a tertiary care hospital. Anales de pediatria, 2023, Volume: 99, Issue:4 Topics: Cerebral Palsy; Enterocolitis, Necrotizing; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Parturition; Pregnancy; Premature Birth; Retrospective Studies; Tertiary Care Centers	2023
Trial sequential analysis: useful or useless? BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:10 Topics: Cerebral Palsy; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Pregnancy	2020
Magnesium sulphate for prevention of cerebral palsy: if not now, when? BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:10 Topics: Cerebral Palsy; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Parturition; Pregnancy; Premature Birth	2020
Linking data from a large clinical trial with the Australian Cerebral Palsy Register. Developmental medicine and child neurology, 2020, Volume: 62, Issue:10 Topics: Australia; Cerebral Palsy; Child, Preschool; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Information Storage and Retrieval; Magnesium Sulfate; Male; Pregnancy; Randomized Controlled Trials as Topic; Registries	2020
Re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: At which gestational ages should magnesium sulphate be given to women at risk of preterm bir BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:10 Topics: Cerebral Palsy; Double-Blind Method; Female; Gestational Age; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Parturition; Pregnancy; Premature Birth	2020
Authors' reply re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: Time range for treatment with magnesium sulphate. BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:10 Topics: Cerebral Palsy; Double-Blind Method; Female; Gestational Age; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Parturition; Pregnancy; Premature Birth	2020
Utilizing registry data to identify children with cerebral palsy previously enrolled in the magnesium sulfate randomized clinical trial. Developmental medicine and child neurology, 2020, Volume: 62, Issue:10 Topics: Australia; Cerebral Palsy; Child; Gestational Age; Humans; Magnesium Sulfate; Registries	2020
Translating antenatal magnesium sulphate neuroprotection for infants born <28 weeks' gestation into practice: A geographical cohort study. The Australian & New Zealand journal of obstetrics & gynaecology, 2021, Volume: 61, Issue:4 Topics: Cerebral Palsy; Child; Child, Preschool; Cohort Studies; Female; Gestational Age; Humans; Infant; Magnesium Sulfate; Neuroprotection; Neuroprotective Agents; Parturition; Pregnancy; Premature Birth; Victoria	2021
Cerebral Palsy in Very Preterm Infants: A Nine-Year Prospective Study in a French Population-Based Tertiary Center. The Journal of pediatrics, 2021, Volume: 237 Topics: Cerebral Palsy; Child, Preschool; Female; France; Humans; Infant, Premature; Longitudinal Studies; Magnesium Sulfate; Male; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Prospective Studies; Tocolytic Agents	2021
Antenatal magnesium sulfate to prevent cerebral palsy. Archives of disease in childhood. Fetal and neonatal edition, 2022, Volume: 107, Issue:2 Topics: Calcium Channel Blockers; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Premature Birth	2022
Head Circumference within the Normal Range and Neurodevelopmental Outcomes in Preterm Infants. American journal of perinatology, 2021, Volume: 38, Issue:14 Topics: Cephalometry; Cerebral Palsy; Child Development; Follow-Up Studies; Head; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neurodevelopmental Disorders; Psychomotor Disorders; Randomized Controlled Trials as Topic; Reference Values; Regression Analysis	2021
Optimization of Maternal Magnesium Sulfate Administration for Fetal Neuroprotection: Application of a Prospectively Constructed Pharmacokinetic Model to the BEAM Cohort. Journal of clinical pharmacology, 2017, Volume: 57, Issue:11 Topics: Cerebral Palsy; Child, Preschool; Cohort Studies; Female; Fetus; Humans; Infant; Infant, Newborn; Magnesium; Magnesium Sulfate; Neuroprotection; Pregnancy	2017
Adherence to uptake of magnesium sulphate for neuroprotection in preterm births <30 weeks at Christchurch Hospital. The New Zealand medical journal, 2017, 07-07, Volume: 130, Issue:1458 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; New Zealand; Pregnancy; Premature Birth; Retrospective Studies	2017
Prenatal Therapy with Magnesium Sulfate and Its Correlation with Neonatal Serum Magnesium Concentration. American journal of perinatology, 2018, Volume: 35, Issue:2 Topics: Case-Control Studies; Cerebral Palsy; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Linear Models; Magnesium; Magnesium Sulfate; Male; Motor Disorders; Neuroprotective Agents; Pregnancy; Prenatal Care; Prospective Studies	2018
Antenatal magnesium for preterm delivery reduces risk of cerebral palsy among surviving very preterm infants. Acta paediatrica (Oslo, Norway : 1992), 2018, Volume: 107, Issue:1 Topics: Cerebral Palsy; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Magnesium; Magnesium Sulfate; Pregnancy; Premature Birth	2018
MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada. Implementation science : IS, 2018, 01-11, Volume: 13, Issue:1 Topics: Canada; Cerebral Palsy; Child; Female; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Neuroprotection; Neuroprotective Agents; Pregnancy	2018
Magnesium sulfate prevents cerebral palsy in premature infants. The Journal of pediatrics, 2018, Volume: 194 Topics: Cerebral Palsy; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy	2018
Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2). American journal of obstetrics and gynecology, 2018, Volume: 219, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Cerebral Palsy; Cesarean Section; Child, Preschool; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Fetal Viability; France; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium Sulfate; Patient Transfer; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Prenatal Care; Retinopathy of Prematurity; Stillbirth; Survival Rate; Tocolysis; Tocolytic Agents	2018
Time- and sex-dependent efficacy of magnesium sulfate to prevent behavioral impairments and cerebral damage in a mouse model of cerebral palsy. Neurobiology of disease, 2018, Volume: 120 Topics: Animals; Animals, Newborn; Anticonvulsants; Brain Injuries; Cerebral Palsy; Disease Models, Animal; Female; Magnesium Sulfate; Male; Mice; Reflex, Righting; Sex Characteristics; Sex Factors; Time Factors; Treatment Outcome	2018
Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses. American journal of obstetrics and gynecology, 2018, Volume: 219, Issue:6 Topics: Adult; Canada; Cerebral Palsy; Cohort Studies; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Neuroprotection; Peripartum Period; Pregnancy; Pregnancy Outcome; Retrospective Studies; Tocolytic Agents	2018
Comparison of Cerebral Palsy Severity Between 2 Eras of Antenatal Magnesium Use. JAMA pediatrics, 2019, 02-01, Volume: 173, Issue:2 Topics: Cerebral Palsy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant, Newborn; Logistic Models; Magnesium Sulfate; Male; Neuroprotective Agents; Ohio; Pregnancy; Premature Birth; Prenatal Care; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2019
Sex-Specific Genetic Susceptibility to Adverse Neurodevelopmental Outcome in Offspring of Pregnancies at Risk of Early Preterm Delivery. American journal of perinatology, 2020, Volume: 37, Issue:3 Topics: Case-Control Studies; Cerebral Palsy; Female; Genetic Predisposition to Disease; Humans; Infant; Interleukin-6; Logistic Models; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Polymorphism, Single Nucleotide; Pregnancy; Premature Birth; Psychomotor Disorders; Sex Factors; Tocolytic Agents	2020
School-age human figure drawings by very preterm infants: Validity of the Draw-a-Man test to detect behavioral and cognitive disorders. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2019, Volume: 26, Issue:4 Topics: Adolescent; Art; Cerebral Palsy; Child; Child Behavior Disorders; Cognition Disorders; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Neuroprotective Agents; Neuropsychological Tests; Prenatal Care; Surveys and Questionnaires	2019
Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand - Ongoing barriers and enablers. The Australian & New Zealand journal of obstetrics & gynaecology, 2020, Volume: 60, Issue:1 Topics: Australia; Cerebral Palsy; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Magnesium Sulfate; Neuroprotective Agents; New Zealand; Pregnancy; Premature Birth; Surveys and Questionnaires; Tocolytic Agents	2020
Magnesium sulphate for the prevention of cerebral palsy in Australia and New Zealand. Australian nursing journal (July 1993), 2013, Volume: 21, Issue:1 Topics: Australia; Cerebral Palsy; Female; Fetus; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; New Zealand; Pregnancy; Premature Birth	2013
Neonatal serum magnesium concentrations are determined by total maternal dose of magnesium sulfate administered for neuroprotection. Journal of perinatal medicine, 2014, Volume: 42, Issue:2 Topics: Anticonvulsants; Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium; Magnesium Sulfate; Pregnancy; Retrospective Studies	2014
Magnesium sulfate for cerebral palsy prevention. Seminars in perinatology, 2013, Volume: 37, Issue:6 Topics: Cerebral Palsy; Drug Administration Schedule; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Practice Guidelines as Topic; Pregnancy; Pregnancy, High-Risk; Prenatal Care; Randomized Controlled Trials as Topic; Tocolytic Agents	2013
Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis. BMC health services research, 2013, Dec-19, Volume: 13 Topics: Cerebral Palsy; Cost Savings; Cost-Benefit Analysis; Decision Trees; Drug Costs; Female; Fetus; Gestational Age; Health Care Costs; Humans; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Quality of Life; Quality-Adjusted Life Years; Risk Assessment	2013
Working to improve survival and health for babies born very preterm: the WISH project protocol. BMC pregnancy and childbirth, 2013, Dec-19, Volume: 13 Topics: Australia; Cerebral Palsy; Child, Preschool; Evidence-Based Medicine; Female; Gestational Age; Guideline Adherence; Hospitals, Maternity; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Medical Audit; Neuroprotective Agents; New Zealand; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prenatal Care; Prospective Studies; Research Design	2013
Fetal pharmacotherapy 3: magnesium sulfate. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2013, Volume: 35, Issue:12 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Premature Birth; Tocolytic Agents	2013
A report from #BlueJC: are we convinced antenatal magnesium sulphate can prevent cerebral palsy in preterm infants? BJOG : an international journal of obstetrics and gynaecology, 2014, Volume: 121, Issue:5 Topics: Central Nervous System Agents; Cerebral Palsy; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care	2014
Disparity in post-treatment maternal circulating magnesium sulfate levels between twin and singleton gestation: Is this the missing link between plurality and adverse outcome? Journal of perinatal medicine, 2015, Volume: 43, Issue:5 Topics: Adult; Case-Control Studies; Cerebral Palsy; Female; Humans; Infant, Newborn; Infusions, Intravenous; Magnesium; Magnesium Deficiency; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Pregnancy Outcome; Pregnancy, Twin; Premature Birth; Regression Analysis	2015
A prospective audit of the adherence to a new magnesium sulphate guideline for the neuroprotection of infants born less than 30 weeks' gestation. The Australian & New Zealand journal of obstetrics & gynaecology, 2015, Volume: 55, Issue:1 Topics: Adult; Anticonvulsants; Cerebral Palsy; Female; Gestational Age; Guideline Adherence; Hospitals, Public; Humans; Magnesium Sulfate; Medical Audit; New Zealand; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prospective Studies; Young Adult	2015
The neuroprotective effect of magnesium sulfate in preterm fetal mice. Journal of perinatal medicine, 2015, Volume: 43, Issue:5 Topics: Animals; Brain; Cells, Cultured; Cerebral Palsy; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Encephalitis; Female; Humans; Inflammation Mediators; Magnesium Sulfate; Mice; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Pregnancy; Premature Birth; S100 Calcium Binding Protein beta Subunit; Tocolytic Agents	2015
Antenatal magnesium sulfate and outcomes for school-aged children. JAMA, 2015, Jan-20, Volume: 313, Issue:3 Topics: Cerebral Palsy; Cognition Disorders; Female; Humans; Infant, Extremely Premature; Magnesium Sulfate; Male; Motor Skills Disorders; Neuroprotective Agents; Pregnancy	2015
Antenatal magnesium sulfate and outcomes for school-aged children--reply. JAMA, 2015, Jan-20, Volume: 313, Issue:3 Topics: Cerebral Palsy; Cognition Disorders; Female; Humans; Infant, Extremely Premature; Magnesium Sulfate; Male; Motor Skills Disorders; Neuroprotective Agents; Pregnancy	2015
Association between Cerebral Palsy or Death and Umbilical Cord Blood Magnesium Concentration. American journal of perinatology, 2015, Volume: 32, Issue:13 Topics: Adult; Case-Control Studies; Cerebral Palsy; Cohort Studies; Female; Fetal Blood; Humans; Infant; Infant Mortality; Infant, Newborn; Magnesium; Magnesium Sulfate; Male; Perinatal Care; Pregnancy; Young Adult	2015
Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women's and Children's Hospital, Adelaide 2010-2013. The Australian & New Zealand journal of obstetrics & gynaecology, 2015, Volume: 55, Issue:3 Topics: Adult; Cerebral Palsy; Cesarean Section; Female; Fetal Distress; Gestational Age; Guideline Adherence; Hospitals, Maternity; Hospitals, Pediatric; Humans; Labor Onset; Magnesium Sulfate; Medical Audit; Parity; Practice Guidelines as Topic; Pregnancy; Premature Birth; South Australia; Tocolytic Agents; Young Adult	2015
Mode of delivery at periviability and early childhood neurodevelopment. American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:4 Topics: Adult; Calcium Channel Blockers; Cerebral Palsy; Cesarean Section; Child Development; Child, Preschool; Cognition; Cohort Studies; Delivery, Obstetric; Female; Fetal Viability; Humans; Infant, Extremely Premature; Longitudinal Studies; Magnesium Sulfate; Motor Skills; Pregnancy; Premature Birth; Prospective Studies; Regression Analysis; Young Adult	2015
Maternal obesity and neuroprotective magnesium sulfate. American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:4 Topics: Adult; Case-Control Studies; Cerebral Palsy; Cohort Studies; Female; Gestational Age; Humans; Infant, Newborn; Logistic Models; Magnesium Sulfate; Neuroprotective Agents; Obesity; Obesity, Morbid; Perinatal Death; Pregnancy; Pregnancy Complications; Premature Birth; Prospective Studies; Treatment Outcome; Young Adult	2015
Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework. BMC pregnancy and childbirth, 2015, Aug-18, Volume: 15 Topics: Attitude of Health Personnel; Cerebral Palsy; Clinical Competence; Female; Guideline Adherence; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Midwifery; Neonatology; Neuroprotective Agents; Obstetrics; Perinatal Death; Practice Guidelines as Topic; Pregnancy; Premature Birth; Reminder Systems; South Australia; Time Factors	2015
Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants. Scientific reports, 2015, Sep-29, Volume: 5 Topics: Adult; Cerebral Palsy; Drug Administration Schedule; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Monitoring, Physiologic; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Retrospective Studies; Tertiary Care Centers	2015
Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada. BMC pregnancy and childbirth, 2015, Dec-22, Volume: 15 Topics: Canada; Cerebral Palsy; Female; Guideline Adherence; Health Personnel; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Societies, Medical; Translational Research, Biomedical	2015
Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan. European journal of obstetrics, gynecology, and reproductive biology, 2016, Volume: 201 Topics: Brain Diseases; Cerebral Palsy; Databases, Factual; Delivery, Obstetric; Dose-Response Relationship, Drug; Female; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Japan; Magnesium Sulfate; Male; Neuroprotective Agents; Perinatal Mortality; Pregnancy; Retrospective Studies	2016
Observations of fetal brain activity via non-invasive magnetoencephalography following administration of magnesium sulfate for neuroprotection in preterm labor. Prenatal diagnosis, 2016, Volume: 36, Issue:10 Topics: Anticonvulsants; Brain; Brain Waves; Cerebral Palsy; Female; Humans; Magnesium Sulfate; Magnetoencephalography; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Premature Birth	2016
Antenatal magnesium sulfate for neuroprotection before preterm birth? The New England journal of medicine, 2008, Aug-28, Volume: 359, Issue:9 Topics: Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents	2008
Magnesium sulfate for the prevention of cerebral palsy. The New England journal of medicine, 2009, Jan-08, Volume: 360, Issue:2 Topics: Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Stillbirth; Tocolytic Agents	2009
MgSO4 for CP prevention: too good to be true? American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:6 Topics: Cerebral Palsy; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate	2009
Magnesium sulfate for the prevention of cerebral palsy. American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:6 Topics: Cerebral Palsy; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Randomized Controlled Trials as Topic	2009
Magnesium sulfate for neuroprotection: what do we do now? Obstetrics and gynecology, 2009, Volume: 114, Issue:3 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium Sulfate; Pregnancy; Premature Birth; Tocolytic Agents	2009
MgSO(4) neuroprophylaxis: going from evidence to recommendation. American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:1 Topics: Cerebral Palsy; Evidence-Based Medicine; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Randomized Controlled Trials as Topic; Risk Assessment	2010
What gestation cut-off should be used for magnesium sulfate treatment of women threatening to deliver preterm? American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:3 Topics: Cerebral Palsy; Clinical Trials as Topic; Female; Gestational Age; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents	2010
Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose. Obstetrics and gynecology, 2010, Volume: 115, Issue:1 Topics: Cerebral Palsy; Contraindications; Female; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents	2010
Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstetrics and gynecology, 2010, Volume: 115, Issue:3 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents	2010
Antenatal magnesium sulphate. BMJ (Clinical research ed.), 2010, Nov-22, Volume: 341 Topics: Cerebral Palsy; Female; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Prenatal Care; Psychomotor Disorders; Randomized Controlled Trials as Topic; Tocolytic Agents	2010
Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants--but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis. BJOG : an international journal of obstetrics and gynaecology, 2011, Volume: 118, Issue:1 Topics: Central Nervous System Agents; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Meta-Analysis as Topic; Pregnancy; Prenatal Care	2011
[Gynecology/Obstetrics. Magnesium sulfate for fetal neuroprotection in preterm delivery. Latest advances in contraception.]. Revue medicale suisse, 2011, Jan-19, Volume: 7, Issue:278 Topics: Cerebral Palsy; Contraceptive Agents, Female; Female; Humans; Magnesium Sulfate; Pregnancy; Premature Birth; Tocolytic Agents	2011
[Evidence exists for prophylactic magnesium sulphate as a neuroprotector in premature births]. Ugeskrift for laeger, 2011, Mar-28, Volume: 173, Issue:13 Topics: Cerebral Palsy; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Maternal-Fetal Exchange; Neuroprotective Agents; Pregnancy; Risk Factors; Tocolytic Agents	2011
The information gap between the required and the actual accrued information size in the meta-analysis of antenatal magnesium sulphate to prevent cerebral palsy in preterm infants. BJOG : an international journal of obstetrics and gynaecology, 2011, Volume: 118, Issue:7 Topics: Central Nervous System Agents; Cerebral Palsy; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care	2011
Antenatal magnesium sulphate to prevent cerebral palsy in very preterm infants. BJOG : an international journal of obstetrics and gynaecology, 2011, Volume: 118, Issue:7 Topics: Central Nervous System Agents; Cerebral Palsy; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care	2011
Short- and long-term outcomes in babies born after antenatal magnesium treatment. The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:11 Topics: Case-Control Studies; Cerebral Hemorrhage; Cerebral Palsy; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Leukomalacia, Periventricular; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Tocolysis; Tocolytic Agents; Treatment Outcome	2011
Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection. Journal of perinatal medicine, 2011, Aug-11, Volume: 40, Issue:2 Topics: Cerebral Palsy; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Retinopathy of Prematurity; Retrospective Studies; Treatment Outcome	2011
Magnesium sulphate for fetal neuroprotection. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2011, Volume: 33, Issue:6 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Prenatal Care	2011
Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis. American journal of obstetrics and gynecology, 2011, Volume: 205, Issue:6 Topics: Anticonvulsants; Cerebral Palsy; Cost-Benefit Analysis; Female; Fetal Membranes, Premature Rupture; Health Care Costs; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Prenatal Care; Quality-Adjusted Life Years; Risk Factors	2011
Magnesium sulfate for fetal neuroprotection. American journal of obstetrics and gynecology, 2011, Volume: 205, Issue:4 Topics: Cerebral Palsy; Fetal Diseases; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents	2011
Magnesium sulfate for neuroprotection in patients at risk for early preterm delivery: not yet. American journal of obstetrics and gynecology, 2011, Volume: 205, Issue:4 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Risk Factors	2011
Obstetric interventions beneficial to prematurely delivering newborn babies: antenatal corticostetroids, progesterone, magnesium sulfate. Clinics in perinatology, 2012, Volume: 39, Issue:1 Topics: Adrenal Cortex Hormones; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Progesterone	2012
Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit. The Australian & New Zealand journal of obstetrics & gynaecology, 2012, Volume: 52, Issue:4 Topics: Australia; Cerebral Palsy; Cohort Studies; Feasibility Studies; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Premature Birth; Retrospective Studies; Tertiary Care Centers; Translational Research, Biomedical	2012
Conclusive meta-analyses on antenatal magnesium may be inconclusive! Are we underestimating the risk of random error? Acta obstetricia et gynecologica Scandinavica, 2012, Volume: 91, Issue:11 Topics: Cerebral Palsy; Female; Humans; Magnesium Sulfate; Pregnancy; Prenatal Care; Tocolytic Agents	2012
Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand. The Australian & New Zealand journal of obstetrics & gynaecology, 2013, Volume: 53, Issue:1 Topics: Australia; Cerebral Palsy; Female; Guideline Adherence; Health Care Surveys; Hospitals, Maternity; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Nervous System Diseases; Neuroprotective Agents; New Zealand; Practice Guidelines as Topic; Pregnancy; Prenatal Care; Tertiary Care Centers	2013
Magnesium sulfate, cerebral palsy prevention, and medical protocols. Obstetrics and gynecology, 2013, Volume: 121, Issue:2 Pt 1 Topics: Cerebral Palsy; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care	2013
Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. American journal of obstetrics and gynecology, 2003, Volume: 189, Issue:2 Topics: Cerebral Hemorrhage; Cerebral Palsy; Cerebral Ventricles; Female; Humans; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents	2003
Hope for perinatal prevention of cerebral palsy. JAMA, 2003, Nov-26, Volume: 290, Issue:20 Topics: Asphyxia Neonatorum; Cerebral Palsy; Chorioamnionitis; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Risk Factors	2003
Magnesium sulfate for preterm neuroprotection. JAMA, 2004, Feb-25, Volume: 291, Issue:8 Topics: Cerebral Palsy; Dose-Response Relationship, Drug; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents	2004
Magnesium sulfate for preterm neuroprotection. JAMA, 2004, Feb-25, Volume: 291, Issue:8 Topics: Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy	2004
The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor. Journal of perinatology : official journal of the California Perinatal Association, 2004, Volume: 24, Issue:7 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents	2004
Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia. Brain & development, 2005, Volume: 27, Issue:1 Topics: Apgar Score; Case-Control Studies; Causality; Cerebral Palsy; Chorioamnionitis; Comorbidity; Female; Gestational Age; Humans; Indomethacin; Infant, Newborn; Leukomalacia, Periventricular; Magnesium Sulfate; Multivariate Analysis; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk Assessment; Umbilical Cord	2005
Antenatal magnesium sulphate neuroprotection in the preterm infant. Seminars in fetal & neonatal medicine, 2007, Volume: 12, Issue:4 Topics: Animals; Cerebral Palsy; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Randomized Controlled Trials as Topic; Treatment Outcome	2007
[Magnetophoresis of glutaminic acid and magnesium sulfate in rehabilitation of children with cerebral palsy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2007, Volume: 107, Issue:12 Topics: Anticonvulsants; Cerebral Palsy; Child; Child, Preschool; Drug Administration Routes; Drug Therapy, Combination; Electroencephalography; Electromyography; Follow-Up Studies; Glutamates; Humans; Infant; Magnesium Sulfate; Magnetics; Muscle Tonus; Treatment Outcome	2007
Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics, 1995, Volume: 95, Issue:2 Topics: Cerebral Palsy; Child, Preschool; Confidence Intervals; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Magnesium Sulfate; Male; Multivariate Analysis; Odds Ratio; Pre-Eclampsia; Pregnancy; Prevalence; Risk Factors; Tocolysis	1995
Cerebral palsy in very low birth weight infants, pre-eclampsia and magnesium sulphate. Pediatrics, 1996, Volume: 97, Issue:5 Topics: Birth Weight; Cerebral Palsy; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Risk Factors; Tocolysis	1996
Prenatal and perinatal factors and cerebral palsy in very low birth weight infants. The Journal of pediatrics, 1996, Volume: 128, Issue:3 Topics: Adult; Case-Control Studies; Cerebral Palsy; Child, Preschool; Chorioamnionitis; Confidence Intervals; Delivery, Obstetric; Female; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Magnesium Sulfate; Obstetric Labor, Premature; Odds Ratio; Pregnancy; Pregnancy Complications; Random Allocation; Risk Factors; Seizures; Time Factors; Tocolytic Agents	1996
The feasibility of a randomized clinical perinatal trial: maternal magnesium sulfate for the prevention of cerebral palsy. American journal of obstetrics and gynecology, 1996, Volume: 175, Issue:3 Pt 1 Topics: Cerebral Palsy; Feasibility Studies; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic; Research Design; Sample Size	1996
Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA, 1996, Dec-11, Volume: 276, Issue:22 Topics: Adult; Cerebral Palsy; Child, Preschool; Cohort Studies; Female; Follow-Up Studies; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Very Low Birth Weight; Intellectual Disability; Magnesium Sulfate; Male; Multivariate Analysis; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Tocolytic Agents	1996
Magnesium sulfate and risk of cerebral palsy in very low-birth-weight infants. JAMA, 1996, Dec-11, Volume: 276, Issue:22 Topics: Cerebral Palsy; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Intellectual Disability; Magnesium Sulfate; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Tocolytic Agents	1996
Prenatal magnesium sulfate exposure and risk of cerebral palsy. JAMA, 1997, Apr-02, Volume: 277, Issue:13 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Tocolysis; Tocolytic Agents	1997
Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. Pediatrics, 1997, Volume: 99, Issue:4 Topics: Adrenal Cortex Hormones; Brain; Cerebral Hemorrhage; Cerebral Palsy; Confounding Factors, Epidemiologic; Echoencephalography; Female; Humans; Hypertension; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Leukomalacia, Periventricular; Logistic Models; Magnesium Sulfate; Odds Ratio; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies	1997
More on prenatal magnesium sulfate and risk of cerebral palsy. JAMA, 1997, Nov-12, Volume: 278, Issue:18 Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium Sulfate; Pregnancy; Risk; Tocolytic Agents	1997
Magnesium sulfate tocolysis and risk of neonatal death. American journal of obstetrics and gynecology, 1998, Volume: 178, Issue:1 Pt 1 Topics: Birth Weight; California; Case-Control Studies; Cerebral Palsy; Female; Gestational Age; Humans; Incidence; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Magnesium Sulfate; Male; Obstetric Labor, Premature; Placenta Diseases; Pre-Eclampsia; Pregnancy; Risk Factors; Tocolysis; Tocolytic Agents; Urinary Tract Infections	1998
Preeclampsia, preterm delivery and infant cerebral palsy. European journal of obstetrics, gynecology, and reproductive biology, 1998, Volume: 77, Issue:2 Topics: Adult; Birth Weight; Cerebral Palsy; Cohort Studies; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Male; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Regression Analysis; Risk Factors; Sex Characteristics	1998
Magnesium sulphate: a review of clinical pharmacology applied to obstetrics. British journal of obstetrics and gynaecology, 1998, Volume: 105, Issue:9 Topics: Anticonvulsants; Cerebral Palsy; Female; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents	1998
Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxia/ischemia in the rat. Pediatric research, 1998, Volume: 44, Issue:5 Topics: Animals; Brain Injuries; Brain Ischemia; Cerebral Palsy; Corpus Striatum; Female; Magnesium Sulfate; Neurons; Oxygen; Pregnancy; Rats; Rats, Sprague-Dawley	1998
Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation. European journal of obstetrics, gynecology, and reproductive biology, 2000, Volume: 91, Issue:2 Topics: Abruptio Placentae; Adolescent; Adult; Birth Weight; Case-Control Studies; Cerebral Palsy; Female; Fetal Membranes, Premature Rupture; Gestational Age; Heart Rate, Fetal; Humans; Logistic Models; Magnesium Sulfate; Maternal Age; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, High-Risk; Risk Factors; Uterine Diseases	2000
Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams. American journal of epidemiology, 2000, Jul-15, Volume: 152, Issue:2 Topics: Adult; Birth Weight; Case-Control Studies; Cerebral Palsy; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Risk Factors; Tocolytic Agents	2000
Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. American journal of obstetrics and gynecology, 2000, Volume: 183, Issue:3 Topics: Birth Weight; Case-Control Studies; Cerebral Palsy; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Logistic Models; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Retrospective Studies; Risk Factors; Tocolysis	2000
Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. Journal of child neurology, 1992, Volume: 7, Issue:1 Topics: Cerebral Hemorrhage; Cerebral Palsy; Double-Blind Method; Female; Humans; Hypertension; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Phenobarbital; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies	1992